Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation (original) (raw)

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

Attilio Bondanza

New England Journal of Medicine, 2009

View PDFchevron_right

Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors

Ryuji Tanosaki

British Journal of Haematology, 2005

View PDFchevron_right

HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism

Hiroh Saji

Blood, 2009

View PDFchevron_right

The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia

Tarek Ben Othman

Bone Marrow Transplantation, 2001

View PDFchevron_right

Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI

I. Jollet

Bone marrow transplantation, 2016

View PDFchevron_right

HLA-mismatched microtransplantation for relapsed or refractory acute myeloid leukemia as a bridge to allogeneic hematopoietic stem cell transplantation

Neeraj Sidharthan

Bone Marrow Transplantation, 2019

View PDFchevron_right

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning …

Richard Maziarz

Biology of Blood and …, 2008

View PDFchevron_right

Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match

Arturo Molina, Koen van Besien

Biology of Blood and Marrow Transplantation, 2008

View PDFchevron_right

Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation

Jacek Nowak

HLA, 2018

View PDFchevron_right

Clinical Significance of HLA-E*0103 Homozygosity on Survival After Allogeneic Hematopoietic Stem-Cell Transplantation

Johannes Pröll

Transplantation, 2009

View PDFchevron_right

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide

Paula Muñiz

Frontiers in Immunology, 2021

View PDFchevron_right

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

mauro marchesi

Blood, 2014

View PDFchevron_right

Bone Marrow Transplantation for Chronic Myeloid Leukemia With Volunteer Unrelated Donors Using Ex Vivo or In Vivo T-cell Depletion: Major Prognostic Impact of HLA Class I Identity Between Donor and Recipient

Richard Szydlo

1995

View PDFchevron_right

Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants

ISABEL Cunningham

Blood, 1989

View PDFchevron_right

HLA Disparity and Rapid Immune Reconstitution Do Not Overcome Propensity to Relapse in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant (HSCT) With Persistent Disease at the Time of Transplant

Onder Alpdogan

Biology of Blood and Marrow Transplantation, 2011

View PDFchevron_right

Transplantation in Remission Improves the Disease-Free Survival of Patients with Advanced Myelodysplastic Syndromes Treated with Myeloablative T Cell-Depleted Stem Cell Transplants from HLA-Identical Siblings

Nancy Kernan

Biology of Blood and Marrow Transplantation, 2008

View PDFchevron_right

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research

Marcelo A Fernandez-vina

Biology of Blood and Marrow Transplantation, 2015

View PDFchevron_right

Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci

Borje Andersson

Biology of Blood and Marrow Transplantation, 2011

View PDFchevron_right

Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor

Hidetoshi Inoko, Hiroh Saji

Biology of Blood and Marrow Transplantation, 2007

View PDFchevron_right

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia

Nathan Punwani

Leukemia Research Reports

View PDFchevron_right

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

Hakan Ozdogu

HAL (Le Centre pour la Communication Scientifique Directe), 2017

View PDFchevron_right

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

R. Hough

Blood, 2010

View PDFchevron_right

Novel strategies for adoptive therapy following HLA disparate transplants

Aisha Hasan

Best Practice & Research Clinical Haematology, 2011

View PDFchevron_right

Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS

Parastoo Dahi

Bone Marrow Transplantation, 2016

View PDFchevron_right

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Kirk Schultz

Blood, 2014

View PDFchevron_right

HLA-Haploidentical Transplantation with Regulatory and Conventional T-Cells Adoptive Immunotherapy in Pediatric Patients with High-Risk Acute Leukemia

mauro marchesi

Transplantation and Cellular Therapy, 2021

View PDFchevron_right

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities

Philip Rowlings

Blood, 2000

View PDFchevron_right

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Kate Matthews

British Journal of Haematology, 2010

View PDFchevron_right

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

Pavel Jindra

Journal of Hematology & Oncology, 2016

View PDFchevron_right

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Michael Maris

Blood, 2003

View PDFchevron_right

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT …

Antonin Vitek

Leukemia, 2010

View PDFchevron_right

Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

Brenda Sandmaier

Biology of Blood and Marrow Transplantation, 2008

View PDFchevron_right

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

John Wingard

Journal of Clinical Oncology, 2012

View PDFchevron_right

HLA Association with Hematopoietic Stem Cell Transplantation Outcome: The Number of Mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 Is Strongly Associated with Overall Survival

Dominique Charron, A. Toubert, Pascale Perrier

Biology of Blood and Marrow Transplantation, 2007

View PDFchevron_right